Middletown, DE -- (SBWIRE) -- 10/28/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), Infinera Corp. (NASDAQ:INFN), Jive Software Inc (NASDAQ:JIVE), Opexa Therapeutics Inc (NASDAQ:OPXA).
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), opened the session at $1.98, remained amid the day range of $1.83 - $1.98, and closed the session at $1.87. The stock showed a negative performance of -3.11% in previous trading session. The stock gained a volume of 1.58 million shares and the average volume of the stock remained 2.78 million shares.
Has CPRX Found The Bottom and Ready To Move Up? Find Out Here
Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company.
Infinera Corp. (NASDAQ:INFN), traded with volume of 1.58 million shares in the prior session and the average volume of the stock remained 1.38 million shares. The 52 week range of the stock remained $4.32 - $12.16. The stock showed a negative movement of -1.35% and closed its session at $10.26. The market capitalization of the stock remained 1.23 billion.
Will INFN Get Buyers Even After The Recent Rally? Find Out Here
Infinera Corporation provides optical networking equipment, software, and services to communications service providers, Internet content providers, cable operators, and subsea network operators worldwide.
Jive Software Inc (NASDAQ:JIVE), exchanged 1.49 million shares and the average volume remained 610,193 shares. The stock escalated1.40% and closed the session at $13.08. The EPS of the stock remained -0.94. The shares outstanding of the stock remained 68.76 million.
Why Should Investors Buy JIVE After The Recent Gain? Find Out Here
Jive Software, Inc. provides a social business software platform to businesses, government agencies, and other enterprises. Its flagship product, the Jive Platform, offers social business capabilities that enable employee, customer, and partner engagement on a unified platform.
Opexa Therapeutics Inc (NASDAQ:OPXA) traded with volume of 1.48 million shares and the average volume of the stock remained 904,639 shares. The stock grew4.81 % and finished the trading at $2.07. The market capitalization of the stock remained 47.05 million. The beta of the stock remained 1.19.
Will OPXA Continue To Move Higher? Find Out Here
Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized cellular therapies to treat multiple sclerosis (MS) based on its proprietary T-cell technology.
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)